Viatris, Inc. (VTRS)

16.88 -0.06 (-0.35%) USD  |  NASDAQ  |  Sep 04, 16:00
16.88 0.00 (0.00%) After-Hours: 20:00
More

Viatris SG&A Expense (TTM) : 3.981B for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for VTRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 3.981B
March 31, 2026 3.775B
December 31, 2025 3.794B
September 30, 2025 3.810B
June 30, 2025 3.927B
March 31, 2025 4.356B
December 31, 2024 4.426B
September 30, 2024 4.985B
June 30, 2024 5.035B
March 31, 2024 4.709B
December 31, 2023 4.650B
September 30, 2023 4.310B
June 30, 2023 4.274B
March 31, 2023 4.223B
December 31, 2022 4.179B
September 30, 2022 3.997B
June 30, 2022 4.034B
March 31, 2022 4.258B
December 31, 2021 4.529B
September 30, 2021 4.808B
June 30, 2021 4.411B
March 31, 2021 3.926B
December 31, 2020 3.345B
September 30, 2020 2.638B
June 30, 2020 2.612B
Date Value
March 31, 2020 2.561B
December 31, 2019 2.564B
September 30, 2019 2.542B
June 30, 2019 2.487B
March 31, 2019 2.441B
December 31, 2018 2.441B
September 30, 2018 2.467B
June 30, 2018 2.554B
March 31, 2018 2.552B
December 31, 2017 2.575B
September 30, 2017 2.625B
June 30, 2017 2.617B
March 31, 2017 2.578B
December 31, 2016 2.496B
September 30, 2016 2.384B
June 30, 2016 2.264B
March 31, 2016 2.247B
December 31, 2015 2.181B
September 30, 2015 2.010B
June 30, 2015 1.891B
March 31, 2015 1.731B
December 31, 2014 1.626B
September 30, 2014 1.580B
June 30, 2014 1.527B
March 31, 2014 1.438B

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Pfizer Inc. 13.72B
Eli Lilly & Co. 12.24B
Merck & Co., Inc. 11.14B
Bristol Myers Squibb Co. 7.413B
Johnson & Johnson 25.14B